Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Biogen Idec reports death of patient on its MS pill
Effect of disease duration on personality type in multiple sclerosis patients and healthy individual.
Neurological involvement in Primary Sjögren Syndrome.
A Safety and Efficacy Extension Study of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis (DreaMS)
Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis.
Two cases of relapses in primary progressive multiple sclerosis after fingolimod withdrawal.
Getting a Handle on Lymphopenia With Tecfidera
Beneficial actions of the anti-inflammatory dimethyl fumarate in glioblastomas.
Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group.
Magnetization transfer ratio in the delayed-release dimethyl fumarate DEFINE study.
Interferon beta-1b in secondary progressive MS: results from a 3-year controlled study.
Central fatigue in multiple sclerosis: a review of the literature.
Epigenetic Modulation of Human Induced Pluripotent Stem Cell Differentiation to Oligodendrocytes.
Emerging oral agents for multiple sclerosis.
Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein.
Interferon beta-1b therapy in chronic viral dilated cardiomyopathy--is there a role for specific therapy?
Multiple sclerosis: A lifestyle disease?
Erratum to: Antibody-mediated neutralization of myelin-associated EphrinB3 accelerates CNS remyelination.
Monomethyl fumarate augments NK cell lysis of tumor cells through degranulation and the upregulation of NKp46 and CD107a.
Effectiveness and cost-effectiveness of interferon beta and glatiramer acetate in the UK Multiple Sclerosis Risk Sharing Scheme at 6 years: a clinical cohort study with natural history comparator.
A Unified Frequency Domain Model to Study the Effect of Demyelination on Axonal Conduction.
Individualized quality of life of severely affected multiple sclerosis patients: practicability and value in comparison with standard inventories.
Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more.
Leflunomide: mode of action in the treatment of rheumatoid arthritis.
The impact of multiple sclerosis relapse treatment on migration of effector T cells - Preliminary study.

Pages